U.S. Market

Contraindicated: Why These 3 Biotech Stocks With Massive Gains Could Be Toxic For Portfolios

by RobH
March 21, 2021April 17, 2021

With a potential treatment for Alzheimer’s disease, a deal to co-develop a proven-effective COVID-19 vaccine for the U.S. market, and a platform of red-blood-cell-based cancer… Read More »Contraindicated: Why These 3 Biotech Stocks With Massive Gains Could Be Toxic For Portfolios

Omnichannel Opportunities Amid The Retail Wreckage

by Bob Mitchell
August 12, 2019April 17, 2021

Cheap is hard to come by in the U.S. market today, but one sector that is cheap is retail. And while many retailers are cheap… Read More »Omnichannel Opportunities Amid The Retail Wreckage

4 Funds To “Cover The Globe” (And Beat The S&P 500)

by Bob Mitchell
January 26, 2018April 17, 2021

Last year investors poured roughly $150 billion into international stocks through exchange-traded funds – and were rewarded for it as global stocks beat the U.S.… Read More »4 Funds To “Cover The Globe” (And Beat The S&P 500)